B1 Vertaisarvioimaton kirjoitus tieteellisessä lehdessä
Highlight selection of radiochemistry and radiopharmacy developments by editorial board
Tekijät: Aime Silvio, Al-Qahtani Mohammed, Behe Martin, Bormans Guy, Carlucci Giuseppe, DaSilva Jean N., Decristoforo Clemens, Duatti Adriano, Elsinga Philip H., Kopka Klaus, Li Xiang-Guo, Liu Zhibo, Mach Robert H., Middel Oskar, Passchier Jan, Patt Marianne, Penuelas Ivan, Rey Ana, Scott Peter J. H., Todde Sergio, Toyohara Jun, Vugts Danielle, Zhi Yang
Kustantaja: SPRINGERNATURE
Julkaisuvuosi: 2021
Journal: EJNMMI Radiopharmacy and Chemistry
Tietokannassa oleva lehden nimi: EJNMMI RADIOPHARMACY AND CHEMISTRY
Lehden akronyymi: EJNMMI RADIOPHARM CH
Artikkelin numero: ARTN 13
Vuosikerta: 6
Sivujen määrä: 19
eISSN: 2365-421X
DOI: https://doi.org/10.1186/s41181-021-00128-x
Verkko-osoite: https://ejnmmipharmchem.springeropen.com/articles/10.1186/s41181-021-00128-x
Rinnakkaistallenteen osoite: https://research.utu.fi/converis/portal/detail/Publication/69169496
Background
The Editorial Board of EJNMMI Radiopharmacy and Chemistry releases a biyearly highlight commentary to update the readership on trends in the field of radiopharmaceutical development.
Results
This commentary of highlights has resulted in 23 different topics selected by each member of the Editorial Board addressing a variety of aspects ranging from novel radiochemistry to first in man application of novel radiopharmaceuticals.
Conclusion
Trends in radiochemistry and radiopharmacy are highlighted demonstrating the progress in the research field being the scope of EJNMMI Radiopharmacy and Chemistry.
Ladattava julkaisu This is an electronic reprint of the original article. |  |
